Logo

Caris Life Sciences: Chadi Nabhan

Apr 14, 2020

Caris Life Sciences has appointed Chadi Nabhan as chairman of its Precision Oncology Alliance, a collaborative network of 36 academic, hospital, and community-based cancer institutions focused on precision medicine. Nabhan was previously chief medical officer of Aptitude Health. Prior to that he was CMO at Cardinal Health Specialty Solutions. Nabhan was also an associate professor of medicine and medical director of the Clinical Cancer Center at the University of Chicago. He is currently an adjunct professor in the Department of Clinical Pharmacy at the University of South Carolina.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.